Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > SundayMovies Member Since: December 01, 2022
View:
Post by Noteable on Dec 07, 2022 10:31am

SundayMovies Member Since: December 01, 2022

Yet another barking dog.
Comment by Noteable on Dec 07, 2022 11:12am
Yet another barking dog with negative commentary cattily disguised as backhanded positive.
Comment by SundayMovies on Dec 07, 2022 11:14am
Unnoteworthy,  I think you are not very knowledgeable and often wrong.  Also, your writing is cryptic, confusing and demonstrate maybe a low mental biomarkers level.  Maybe the AWARE trial will help you. Maybe not. I think it will be the latter.
Comment by SundayMovies on Dec 07, 2022 11:18am
Unnoteworthy,  Are you a cat person? Is that why there are multiple references to dogs and dog barking?  Finally, low mental biomarker level is an uncurable condition... 
Comment by Noteable on Dec 07, 2022 11:22am
Well this was confirmed in quick time ... Yet another barking dog with negative commentary "discordantly" disguised as backhanded positive
Comment by SundayMovies on Dec 07, 2022 11:26am
That's it???? That's your rebuttal for low mental biomarker level... barking dog... Wow.  The trial result is over and the results confirms it.... 
Comment by Noteable on Dec 07, 2022 11:30am
Furthermore, SundayMovies uses the alias "R" on the yahoo message board. Another of those rats !
Comment by SundayMovies on Dec 07, 2022 11:34am
Wow yahoo message board what are you talking about??? Barking Rats now??? Wow. 
Comment by Noteable on Dec 07, 2022 11:38am
Yep ... its all about YOU .. the one who keeps posting "sweet nothings" and rat poison.
Comment by SundayMovies on Dec 07, 2022 11:44am
This conversation is making no sense by the way... and the non-sense is all about rats dogs and something about barking issues... now "sweet nothings"... wow there is even a now darker emerging theme... wow.  Who let the dog out from your brain??? Whomever, please stop.
Comment by Davepark5 on Dec 07, 2022 11:52am
This post has been removed in accordance with Community Policy
Comment by Normandt on Dec 07, 2022 12:28pm
""Sunday please don;t let the autistic board spamming fool noteable discourage you from posting your excellent observations and thoughts.   This guy clearly needs strong medication.   Half the junk he posts is not even relevant."" I'm not sure who needs strong medication here.   
Comment by jimsenior on Dec 07, 2022 12:43pm
@Normandt. I too, think Noteable's info is very helpful in many ways.  I am holding my small position very tightly.  Cheers
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities